Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial - IRD - Institut de recherche pour le développement Access content directly
Conference Papers Year : 2015

Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial

Fichier principal
Vignette du fichier
Larmarange_TasP_ANRS12249_INTEREST_2015-05.pdf (1.17 Mo) Télécharger le fichier
Origin Files produced by the author(s)
Licence

Dates and versions

ird-04112528 , version 1 (31-05-2023)

Licence

Identifiers

  • HAL Id : ird-04112528 , version 1

Cite

Joseph Larmarange. Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial. 9th INTEREST Workshop, May 2015, Harare, Zimbabwe. ⟨ird-04112528⟩
6 View
8 Download

Share

Gmail Mastodon Facebook X LinkedIn More